The clinical cases are to gain an understanding of the diagnosis and management of some of the rarer and more unusual dermatology conditions and unusual presentations of common dermatological problems.
Benefits of attending:
For those attending in person, the clinical cases will be followed by a drinks reception to facilitate networking.
Book to attend this event in person or virtually. To view the rates and agenda, please select your preference below.
Attendance criteria
You can only attend this meeting if you hold a Consultant or training post, are a SAS doctor or a clinical fellow in full time dermatology. You must bring ID with you to show this. Exceptions are made for those who are Section members (by completing an additional application form) who have made significant contributions to dermatology and are of good standing in the profession.
This event will be recorded* and all registered delegates will be able to access the recording for 60 days after. The link will be distributed 3 days after the event takes place.
Follow us on:
Facebook
Instagram
LinkedIn
Twitter
YouTube
The Dermatology Section would like to thank our Annual Sponsors AbbVie, Almirall Ltd, Bristol Myers Squibb, Eucerin, Incyte, La Roche-Posay & Cerave, Lilly, Pfizer, Regeneron, Sanofi and UCB Pharma Ltd for their valued support of the 2024 to 2025 Academic Programme. We would also like to thank our sponsors Aveeno®, Galderma, Glenmark Pharmaceuticals, Johnson & Johnson Innovative Medicine, LEO Pharma and Novartis for their support of this meeting.
Please note that none of the companies listed has had any influence or involvement over the agenda, content or organisation of the meetings.
Members only
Dr Anshoo Sahota, President, Dermatology Section, Royal Society of Medicine
Dr Daniel Lyons, Registrar, The Mater Misericordiae University Hospital Dublin on behalf of Dr Emma Shudell, Consultant Dermatologist, The Mater Misericordiae University Hospital Dublin
Dr Michael Atkinson, Dermatology Senior Clinical Fellow, Royal Free London NHS Foundation Trust, second author Dr Saerrah Murryam, Specialty Trainee Year 3, Kingston and Richmond NHS Foundation Trust on behalf of Dr Fiona Child, Consultant Dermatologist, Guy's and St Thomas' NHS Foundation Trust and Dr Janakan Natkunarajah, Consultant Dermatologist, Kingston and Richmond NHS Foundation Trust
Dr Nikesh Patel, Specialty Trainee Year 5, St George's University Hospitals NHS Foundation Trust on behalf of Dr Ruth Lamb, Consultant Dermatologist, St George's University Hospitals NHS Foundation Trust
Dr Saerrah Murryam, Specialty Trainee Year 3, Kingston and Richmond NHS Foundation Trust on behalf of Dr Janakan Natkunarajah, Consultant Dermatologist, Kingston and Richmond NHS Foundation Trust
Dr Anna Nielsen-Scott, Dermatology Clinical Fellow, St George's University Hospitals NHS Foundation Trust on behalf of Dr Alya Abdul-Wahab, Consultant Dermatologist, Leila Ferguson, Consultant Dermatologist, Dr Jeremy Pryce, Consultant Paediatric Pathologist, and Dr Richard Griffiths, Consultant Histopathologist, St George's University Hospitals NHS Foundation Trust
Dr Hsiu Tzu Tung, Dermatology Specialty Registrar, Lewisham and Greenwich NHS Trust
Dr Maha Egail, Clinical Fellow, St George's University Hospitals NHS Foundation Trust on behalf of Dr Victoria Akhras, Consultant Dermatologist, St George's University Hospitals NHS Foundation Trust, Dr Nicholas Tiffin, Consultant Dermatopathologist, St George's University Hospitals NHS Foundation Trust, Dr Louis Flood, Professor Helen Lachman, Professor of Medicine and Honorary Consultant, Royal Free Hospital, Dr Charalampia Papadopoulou, Consultant Paediatric Rheumatologsit, Great Ormond Street Hospital for Children NHS Foundation Trust, and Professor David Jayne, Professor of Surgery, University of Leeds
Live stream:
Sponsored industry presentation by Incyte
Opzelura: Now you can put vitiligo in the spotlight video
Sponsored industry presentation by Almirall Ltd
EBGLYSS ▼(lebrikiziumab) clinical data: What do the trials show
Dr Anshoo Sahota
Members only
Dr Anshoo Sahota, President, Dermatology Section, Royal Society of Medicine
Dr Daniel Lyons, Registrar, The Mater Misericordiae University Hospital Dublin on behalf of Dr Emma Shudell, Consultant Dermatologist, The Mater Misericordiae University Hospital Dublin
Dr Michael Atkinson, Dermatology Senior Clinical Fellow, Royal Free London NHS Foundation Trust, second author Dr Saerrah Murryam, Specialty Trainee Year 3, Kingston and Richmond NHS Foundation Trust on behalf of Dr Fiona Child, Consultant Dermatologist, Guy's and St Thomas' NHS Foundation Trust and Dr Janakan Natkunarajah, Consultant Dermatologist, Kingston and Richmond NHS Foundation Trust
Dr Nikesh Patel, Specialty Trainee Year 5, St George's University Hospitals NHS Foundation Trust on behalf of Dr Ruth Lamb, Consultant Dermatologist, St George's University Hospitals NHS Foundation Trust
Dr Saerrah Murryam, Specialty Trainee Year 3, Kingston and Richmond NHS Foundation Trust on behalf of Dr Janakan Natkunarajah, Consultant Dermatologist, Kingston and Richmond NHS Foundation Trust
Dr Anna Nielsen-Scott, Dermatology Clinical Fellow, St George's University Hospitals NHS Foundation Trust on behalf of Dr Alya Abdul-Wahab, Consultant Dermatologist, Leila Ferguson, Consultant Dermatologist, Dr Jeremy Pryce, Consultant Paediatric Pathologist, and Dr Richard Griffiths, Consultant Histopathologist, St George's University Hospitals NHS Foundation Trust
Dr Hsiu Tzu Tung, Dermatology Specialty Registrar, Lewisham and Greenwich NHS Trust
Dr Maha Egail, Clinical Fellow, St George's University Hospitals NHS Foundation Trust on behalf of Dr Victoria Akhras, Consultant Dermatologist, St George's University Hospitals NHS Foundation Trust, Dr Nicholas Tiffin, Consultant Dermatopathologist, St George's University Hospitals NHS Foundation Trust, Dr Louis Flood, Professor Helen Lachman, Professor of Medicine and Honorary Consultant, Royal Free Hospital, Dr Charalampia Papadopoulou, Consultant Paediatric Rheumatologsit, Great Ormond Street Hospital for Children NHS Foundation Trust, and Professor David Jayne, Professor of Surgery, University of Leeds
Live stream:
Sponsored industry presentation by Incyte
Opzelura: Now you can put vitiligo in the spotlight video
Sponsored industry presentation by Almirall Ltd
EBGLYSS ▼(lebrikiziumab) clinical data: What do the trials show
Dr Anshoo Sahota
Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom
Registration for this event will close at 1:00am on Wednesday 18 June 2025. Late registrations will not be accepted.
The agenda is subject to change at any time
If the event is recorded, we are only able to share presentations that we have received permission to share. There is no guarantee that all sessions will be available after the event, this is at the presenter’s and RSM discretion.
All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.
This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.
